Choline Alfoscerate Topical Compositions for Mucosal Integrity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current compositions lack effective solutions for maintaining and restoring the integrity of mucous membranes, which can be affected by various exogenous and endogenous factors, leading to inflammatory disorders and lesions.
Innovation Solution
Topical compositions containing choline alfoscerate, potentially combined with hyaluronic acid, are developed to enhance cell trophism and mucoadhesion, providing therapeutic benefits for mucous membranes through formulations like gels, creams, and sprays, suitable for human and veterinary use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If topical compositions are used to treat mucous membranes, then therapeutic efficacy is improved, but irritation and toxicity may occur
Solution Approach 1:
The patent changes the chemical parameters of the active ingredient by using choline alfoscerate, a derivative with modified properties compared to conventional agents. This chemical modification allows achieving therapeutic effects while reducing irritation and toxicity, directly resolving the contradiction between efficacy and safety
Solution Approach 2:
The patent employs composite formulations combining choline alfoscerate with specific excipients and co-active ingredients that enhance therapeutic efficacy while providing a protective effect that reduces irritation. The composite nature of the composition allows simultaneous achievement of high efficacy and low toxicity
2Reliability
If conventional treatments are used for mucous membrane disorders, then some therapeutic effect is achieved, but they fail to effectively maintain and restore mucosal tissue integrity
Solution Approach 1:
The patent applies parameter changes by using choline alfoscerate, which has specific biochemical properties that enable it to penetrate and repair mucosal tissue more effectively than conventional treatments. The modified chemical structure allows for better restoration of tissue integrity while maintaining therapeutic effects
Solution Approach 2:
Choline alfoscerate acts as an intermediary substance that mediates between the external environment and the mucosal tissue, facilitating repair and restoration processes. It serves as a carrier that delivers therapeutic benefits while protecting the delicate mucosal structures during the treatment process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Choline alfoscerate improves mucoadhesion and therapeutic efficacy, effectively maintaining and restoring mucosal tissue integrity, addressing inflammatory disorders and lesions, while being minimally irritating and systemically non-toxic.
Implementation Method 1
topical use of choline alfoscerate on the mucous membranes aids their cell trophism, thus maintaining and restoring the integrity of the mucosal tissue
Implementation Method 2
Choline alfoscerate improves mucoadhesion and therapeutic efficacy
Data Source
AI summary
The present invention relates to topical compositions containing choline alfoscerate for use in maintaining and restoring the integrity of the mucous membranes.